Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Small Cell Lung Carcinoma and ALK[original query] |
|---|
| Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression. Molecular cancer 2010 9 (1): 188. Zhang Xuchao, Zhang Shirley, Yang Xuening, Yang Jinji, Zhou Qing, Yin Lucy, An Shejuan, Lin Jiaying, Chen Shiliang, Xie Zhi, Zhu Mike, Zhang Xiaolin, Wu Yi-lo |
| Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Mar 24 (3): 742-8. Ilie M, Long E, Hofman V, Dadone B, Marquette C H, Mouroux J, Vignaud J M, Begueret H, Merlio J P, Capper D, von Deimling A, Emile J F, Hofman |
| Mutated ephrin receptor genes in non-small cell lung carcinoma and their occurrence with driver mutations-targeted resequencing study on formalin-fixed, paraffin-embedded tumor material of 81 patients. Genes, chromosomes & cancer 2013 Dec 52 (12): 1141-9. Mäki-Nevala Satu, Kaur Sarhadi Virinder, Tuononen Katja, Lagström Sonja, Ellonen Pekka, Rönty Mikko, Wirtanen Aino, Knuuttila Aija, Knuutila Saka |
| Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology. Oncotarget 2016 Jul . Zhang Shirong, Xia Bing, Jiang Hong, Wang Limin, Xu Rujun, Shi Yanbin, Zhang Jianguang, Xu Mengnan, Cram David S, Ma Shengl |
| Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Apr . Schneider Frank, Derrick Veronica, Davison Jon M, Strollo Diane, Incharoen Pimpin, Dacic San |
| Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases. Cancer cytopathology 2016 Mar . Allison Derek B, Lilo Mohammed T, Geddes Susan, Pallavajjalla Aparna, Askin Frederic, Gabrielson Edward, Zheng Gang, Li Qing K |
| Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients. Pathology 2017 Aug . Russell Prudence A, Rogers Toni-Maree, Solomon Benjamin, Alam Naveed, Barnett Stephen A, Rathi Vivek, Williams Richard A, Wright Gavin M, Conron Matth |
| Relationship between driver gene mutations, their relative protein expressions and survival in non-small cell lung carcinoma in Macao. The clinical respiratory journal 2017 Jul . Chan Kin Iong, Vong Hong Ting, Sin Lai Fong, Yip Yuk Ching, Zhong Xue Yun, Wen Jian Mi |
| Comprehensive profiling and quantitation of oncogenic mutations in non-small cell lung carcinoma using single-molecule amplification and re-sequencing technology. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Feb 39 (2): 1010428317691413. Shi Jian, Yuan Meng, Wang Zhan-Dong, Xu Xiao-Li, Hong Lei, Sun Shengl |
| [Clinical significance and mechanism of upregulation of PI3Kp110? in non-small cell lung carcinoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2017 Oct 39 (10): 737-743. Xiong Y, Qu L L, Li D, Wang Y, Li |
| Identification of genome variations in patients with lung adenocarcinoma using whole genome re?sequencing. Molecular medicine reports 2017 10 16 (6): 9464-9472. Li Guiyuan, Mei Yunqing, Yang Fan, Yi Shengming, Wang Lem |
| A study of therapy targeted EGFR/ALK mutations in Indian patients with lung adenocarcinoma: A clinical and epidemiological study. Medical journal, Armed Forces India 2018 Apr 74 (2): 148-153. Rana Vandana, Ranjan Praveer, Jagani Rajat, Rathi K R, Kumar Dharmesh, Khera Anur |
| Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes. Molecular cancer therapeutics 2019 Jun . Couëtoux du Tertre Mathilde, Marques Maud, Tremblay Lise, Bouchard Nicole, Diaconescu Razvan, Blais Normand, Couture Christian, Pelsser Vincent, Wang Hangjun, Higenell Valerie, Izzi Luisa, Gambaro Karen, Hoffert Cyrla, Srivastava Archana, Spatz Alan, Rousseau Caroline, McNamara Suzan, Cohen Victor, Batist Gerald, Agulnik Jas |
| How clinically useful is comprehensive genomic profiling for patients with non-small cell lung cancer? A systematic review. Critical reviews in oncology/hematology 2021 8 166 103459. Torres Gabriel Fernando, Bonilla Carlos Eduardo, Buitrago Giancarlo, Arrieta Oscar, Malapelle Umberto, Rolfo Christian, Cardona Andrés |
| Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China. Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
| Lung Cancer in Bahrain: Histological and Molecular Features. The Gulf journal of oncology 2020 Sep 1 (34): 48-51. Mubarak Aalaa, Aljufairi Eman, Almahari Sayed A |
| The prognostic role of PD-1, PD-L1, ALK, and ROS1 proteins expression in non-small cell lung carcinoma patients from Egypt. Journal of the Egyptian National Cancer Institute 2022 6 34 (1): 23. Bahnassy Abeer A, Ismail Hoda, Mohanad Marwa, El-Bastawisy Ahmed, Yousef Hend |
| Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
| Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective. Pathology, research and practice 2023 12 253 155013. Aditi Aggarwal, Shivani Sharma, Zoya Brar, Vipin Kumar, Akash Kumar, Rahul Katara, Sambit K Mohan |
| PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
- Page last reviewed:Feb 1, 2024
- Content source: